Serum free thiols in type 2 diabetes mellitus: A prospective study.
Free sulfhydryl
Glycemia
Oxidative stress
Thiols
Type 2 diabetes
Journal
Journal of clinical & translational endocrinology
ISSN: 2214-6237
Titre abrégé: J Clin Transl Endocrinol
Pays: Netherlands
ID NLM: 101629335
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
02
11
2018
revised:
04
02
2019
accepted:
04
02
2019
entrez:
23
3
2019
pubmed:
23
3
2019
medline:
23
3
2019
Statut:
epublish
Résumé
Oxidative stress is a driver in the development of type 2 diabetes (T2DM) complications. As thiols (R-SH) are oxidized by reactive oxygen and sulfur species, circulating concentrations may directly reflect systemic redox status. We hypothesized that high serum R-SH concentrations are a reflection of a favourable redox status and may therefore positively associate with disease status. R-SH were measured in serum of 943 T2DM outpatients (55% males, 65 years and HbA1c of 6.7% (50 mmol/mol)) with a follow-up period of 1.2 years. In the highest R-SH tertile patients were younger, more often men, had less microvascular complications, lower HbA1c and were more often treated nutritionally or with oral glucose-lowering drugs. Age- and sex adjusted hazard ratios for developing micro-, macro- or any complication plus death were 0.994, 0.992 and 0.993: even after adjustment for potential confounders. The Harrell's C statistic to predict microvascular complications or any complication plus death was higher in the models with R-SH than in those without R-SH. Although R-SH concentrations were associated with a favourable disease status, it did not add to the predictive capacity for long-term complications. Based on the current data R-SH seems unsuitable as a prognostic marker in T2DM.
Identifiants
pubmed: 30899672
doi: 10.1016/j.jcte.2019.100182
pii: S2214-6237(18)30136-4
pii: 100182
pmc: PMC6407140
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100182Références
Arch Biochem Biophys. 1959 May;82(1):70-7
pubmed: 13650640
Stat Med. 2004 Mar 15;23(5):723-48
pubmed: 14981672
Tohoku J Exp Med. 2004 Jul;203(3):211-8
pubmed: 15240931
Diabetes. 2005 Jun;54(6):1615-25
pubmed: 15919781
Arch Iran Med. 2009 Mar;12(2):121-7
pubmed: 19249880
Mediators Inflamm. 2010;2010:453892
pubmed: 20182627
Eur J Pharmacol. 2010 Jun 25;636(1-3):8-17
pubmed: 20371238
Cell Signal. 2012 May;24(5):981-90
pubmed: 22286106
Free Radic Biol Med. 2013 Dec;65:244-253
pubmed: 23747983
J Diabetes Complications. 2013 Nov-Dec;27(6):548-52
pubmed: 24012111
Diabetes Res Clin Pract. 2014 Apr;104(1):1-52
pubmed: 24508150
BMC Endocr Disord. 2014 Mar 04;14:22
pubmed: 24593656
Biochim Biophys Acta. 2014 Sep;1840(9):2709-29
pubmed: 24905298
Redox Biol. 2015;4:180-3
pubmed: 25588755
Antioxid Redox Signal. 2015 Sep 20;23(9):734-46
pubmed: 25891126
J Drug Target. 2017 Feb;25(2):93-101
pubmed: 27356044
Pharmacol Res. 2016 Sep;111:452-458
pubmed: 27378569
Free Radic Biol Med. 2016 Oct;99:345-351
pubmed: 27554970
Saudi Pharm J. 2016 Sep;24(5):547-553
pubmed: 27752226
Eur J Gen Pract. 2017 Dec;23(1):83-90
pubmed: 28326866
Antioxid Redox Signal. 2017 Oct 1;27(10):684-712
pubmed: 28398072
J Lab Clin Med. 1993 Feb;121(2):257-62
pubmed: 8381845
Lifetime Data Anal. 1998;4(2):109-20
pubmed: 9658770